3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
12
Carcinoma, Ovarian Epithelial
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Ovarian Neoplasms
4
Lung Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Intraductal, Noninfiltrating
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Central Nervous System Neoplasms
3
Breast Carcinoma In Situ
3
Brain Neoplasms
3
Pancreatic Neoplasms
2
Lymphoma, Large-Cell, Anaplastic
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Gliosarcoma
2
Glioblastoma
2
Esophageal Neoplasms
2
Adenocarcinoma Of Esophagus
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Interventions
Cisplatin
45
Radiotherapy
32
Fluorouracil
27
Paclitaxel
26
Irinotecan
17
Docetaxel
16
Oxaliplatin
11
Carboplatin
10
pembrolizumab
9
Cetuximab
8
tislelizumab
7
Surgical Procedures, Operative
7
Neoadjuvant Therapy
7
Drug Therapy
7
Radiation
6
Leucovorin
6
sintilimab
5
Nivolumab
5
Immunohistochemistry
5
Chemotherapy, Adjuvant
5
Capecitabine
5
nedaplatin
3
durvalumab
3
camrelizumab
3
S 1 (combination)
3
Magnetic Resonance Spectroscopy
3
Gene Expression Profiling
3
Gemcitabine
3
Fluorodeoxyglucose F18
3
Erlotinib Hydrochloride
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Esophageal Squamous Cell Carcinoma
×
Mass Spectrometry
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled